Skip to main content

Learning Objectives

  • Brief primer on what qualifies as “access” under HIPAA for both routine healthcare and clinical trial operations
  • Review of OCR enforcement and issues related to access via recent audits and case precedent
  • Best practices review of data flow and proper accessibility in the life cycle of a clinical trial
  • Forecasting the next trend for OCR enforcement and HIPAA in these spaces: Information Blocking